Cargando…
A Study on Weight Loss Cause as per the Side Effect of Liraglutide
PURPOSE: Liraglutide is known to have much lower weight loss effects in real clinical fields than in randomized clinical trials because of its side effects (SE) and discomfort associated with injections. This study is aimed at determining whether the side effects of liraglutide affect weight reducti...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9733986/ https://www.ncbi.nlm.nih.gov/pubmed/36540096 http://dx.doi.org/10.1155/2022/5201684 |
_version_ | 1784846492645720064 |
---|---|
author | Yu, Jin Lee, Jeongmin Lee, Seung-Hwan Cho, Jae-Hyung Kim, Hun-Sung |
author_facet | Yu, Jin Lee, Jeongmin Lee, Seung-Hwan Cho, Jae-Hyung Kim, Hun-Sung |
author_sort | Yu, Jin |
collection | PubMed |
description | PURPOSE: Liraglutide is known to have much lower weight loss effects in real clinical fields than in randomized clinical trials because of its side effects (SE) and discomfort associated with injections. This study is aimed at determining whether the side effects of liraglutide affect weight reduction and its maintenance in real-world practice. METHODS: Endocrinologists conducted a retrospective chart review of data from two tertiary university hospitals. All patients who had been prescribed liraglutide at least once between January 2014 and December 2019 were included. For an average of 3 and 6 months, weight changes due to the presence or absence of SE and discontinuation (MAIN or STOP) of liraglutide were checked. RESULTS: Only 40.8% (64/157) of the patients remained on liraglutide for 6 months; 14.7% (23/157) maintained the drug despite SEs (MAIN_SE(+)), and 40.1% (63/157) discontinued the drug despite not having SEs (STOP_SE(-)). At 3 months, there was −5.9 ± 0.6%, −7.9 ± 0.9%, −4.5 ± 0.5%, and −3.4 ± 0.6% weight reduction in the MAIN_SE(-), MAIN_SE(+), STOP_SE(-), and STOP_SE(+) groups, respectively (all p < 0.001 compared to the baseline). However, there were no significant differences in the weight loss between the MAIN (p = 0.062) and STOP (p = 0.204) groups. At 6 months, the weight reduction was −2.0 ± 0.5% (p < 0.001) in MAIN_SE(-), −2.2 ± 0.7% (p < 0.005) in MAIN_SE(+), −1.7 ± 0.7% (p < 0.01) in STOP_SE(-), and −2.0 ± 0.6% (p = 0.01) in STOP_SE(+), compared to baseline. SEs also caused no significant differences in weight loss between the MAIN (p = 0.787) and STOP (p = 0.694) groups. CONCLUSIONS: Our study confirmed that the side effects of liraglutide did not affect weight reduction. Moreover, in the real world, the continuous rate of liraglutide use is not high, and the weight gradually increases after 3 months. Therefore, in addition to the side effects of liraglutide, the medical staff should consider various factors that affect drug adherence, consider ways to increase compliance, and continue to ensure management so that patients can maintain their weight. |
format | Online Article Text |
id | pubmed-9733986 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Hindawi |
record_format | MEDLINE/PubMed |
spelling | pubmed-97339862022-12-19 A Study on Weight Loss Cause as per the Side Effect of Liraglutide Yu, Jin Lee, Jeongmin Lee, Seung-Hwan Cho, Jae-Hyung Kim, Hun-Sung Cardiovasc Ther Research Article PURPOSE: Liraglutide is known to have much lower weight loss effects in real clinical fields than in randomized clinical trials because of its side effects (SE) and discomfort associated with injections. This study is aimed at determining whether the side effects of liraglutide affect weight reduction and its maintenance in real-world practice. METHODS: Endocrinologists conducted a retrospective chart review of data from two tertiary university hospitals. All patients who had been prescribed liraglutide at least once between January 2014 and December 2019 were included. For an average of 3 and 6 months, weight changes due to the presence or absence of SE and discontinuation (MAIN or STOP) of liraglutide were checked. RESULTS: Only 40.8% (64/157) of the patients remained on liraglutide for 6 months; 14.7% (23/157) maintained the drug despite SEs (MAIN_SE(+)), and 40.1% (63/157) discontinued the drug despite not having SEs (STOP_SE(-)). At 3 months, there was −5.9 ± 0.6%, −7.9 ± 0.9%, −4.5 ± 0.5%, and −3.4 ± 0.6% weight reduction in the MAIN_SE(-), MAIN_SE(+), STOP_SE(-), and STOP_SE(+) groups, respectively (all p < 0.001 compared to the baseline). However, there were no significant differences in the weight loss between the MAIN (p = 0.062) and STOP (p = 0.204) groups. At 6 months, the weight reduction was −2.0 ± 0.5% (p < 0.001) in MAIN_SE(-), −2.2 ± 0.7% (p < 0.005) in MAIN_SE(+), −1.7 ± 0.7% (p < 0.01) in STOP_SE(-), and −2.0 ± 0.6% (p = 0.01) in STOP_SE(+), compared to baseline. SEs also caused no significant differences in weight loss between the MAIN (p = 0.787) and STOP (p = 0.694) groups. CONCLUSIONS: Our study confirmed that the side effects of liraglutide did not affect weight reduction. Moreover, in the real world, the continuous rate of liraglutide use is not high, and the weight gradually increases after 3 months. Therefore, in addition to the side effects of liraglutide, the medical staff should consider various factors that affect drug adherence, consider ways to increase compliance, and continue to ensure management so that patients can maintain their weight. Hindawi 2022-12-02 /pmc/articles/PMC9733986/ /pubmed/36540096 http://dx.doi.org/10.1155/2022/5201684 Text en Copyright © 2022 Jin Yu et al. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Article Yu, Jin Lee, Jeongmin Lee, Seung-Hwan Cho, Jae-Hyung Kim, Hun-Sung A Study on Weight Loss Cause as per the Side Effect of Liraglutide |
title | A Study on Weight Loss Cause as per the Side Effect of Liraglutide |
title_full | A Study on Weight Loss Cause as per the Side Effect of Liraglutide |
title_fullStr | A Study on Weight Loss Cause as per the Side Effect of Liraglutide |
title_full_unstemmed | A Study on Weight Loss Cause as per the Side Effect of Liraglutide |
title_short | A Study on Weight Loss Cause as per the Side Effect of Liraglutide |
title_sort | study on weight loss cause as per the side effect of liraglutide |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9733986/ https://www.ncbi.nlm.nih.gov/pubmed/36540096 http://dx.doi.org/10.1155/2022/5201684 |
work_keys_str_mv | AT yujin astudyonweightlosscauseasperthesideeffectofliraglutide AT leejeongmin astudyonweightlosscauseasperthesideeffectofliraglutide AT leeseunghwan astudyonweightlosscauseasperthesideeffectofliraglutide AT chojaehyung astudyonweightlosscauseasperthesideeffectofliraglutide AT kimhunsung astudyonweightlosscauseasperthesideeffectofliraglutide AT yujin studyonweightlosscauseasperthesideeffectofliraglutide AT leejeongmin studyonweightlosscauseasperthesideeffectofliraglutide AT leeseunghwan studyonweightlosscauseasperthesideeffectofliraglutide AT chojaehyung studyonweightlosscauseasperthesideeffectofliraglutide AT kimhunsung studyonweightlosscauseasperthesideeffectofliraglutide |